2010 Program Agenda
 
13 – Dec 6:00 pm – 8:00 pm Registration Open
6:30 pm – 8:00 pm Welcome Reception
     
14 – Dec 7:00 am – 7:00 pm Registration Open
7:00 am – 8:00 am Breakfast featuring Therapeutic Affinity Roundtables
8:00 am – 9:15 am
Opening Plenary Session - Innovation: Where Is It Coming From?
9:30 am – 11:55 am Partnering & Expert Consultations
9:30 am – 10:25 am
Session 1: Medical Research to Care: Closing the Learning Loop
Session 2: Unlocking Data to Drive Discovery
Session 3: Harnessing the Serendipity of Science
10:30 am – 11:00 am Innovator Presentations 1 – 3
1. Product Development Partnership for a Malaria Vaccine: PATH Malaria Vaccine Initiative, GlaxoSmithKline Biologicals
2. Multiple Myeloma Research Foundation, Personalized Medicine Initiative
3. Cancer E-Life Collaboration
11:00 am – 11:25 am Innovator Presentations 4 – 6
4. Tolerx-Cancer Research Institute Acceleration Fund
5. Cerebrospinal Fluid Quality Control Initiative
6. Cancer Commons
11:30 am – 2:15 pm
 Luncheon Plenary Sessions
12:00 pm – 12:45 pm News from the FDA: Drug Development in the Age of Targeted Therapy
12:50 pm – 1:25 pm Science at the FDA: Vision and Execution
1:30 pm – 2:15 pm Are Unmet Patient Needs Driving R&D Investment?
2:30 pm – 6:25 pm Partnering & Expert Consultations
2:30 pm – 2:55 pm Innovator Presentations 7 - 10
7. Seaside Therapeutics, Merck, NIH, FRAXA, and Autism Speaks
8. Accelerated Cure Project Biorepository
9. LaunchPad Fund, Biomedical Innovation in Diabetes
  10. International Partnership for Microbicides
3:00 pm – 3:25 pm Innovator Presentations 11 - 14
11. Melanoma Research Alliance Academic-Industrial Partnership Awards
12. OncoNet
13. Drug Discovery Center of Innovation
  14. Health Impact Fund Pilot, Incentives for Global Health
3:30 pm – 3:55 pm Innovator Presentations 15 - 18
15. Ivy Genomics Based Medicine Project
16. Enabling Molecularly Informed Cancer Medicine, National Cancer Institute
17. DART Therapeutics
  18. findAKUre
4:00 pm – 4:25 pm Innovator Presentations 19 - 22
19. International AIDS Vaccine Initiative, Innovation Fund
20. Discontinued Clinical Compound Library: Academic Drug Repositioning
21. BioPontis Alliance
22. The Epilepsy Study Consortium
4:30 pm – 5:25 pm
Session 4: Building a 21st Century Regulatory Environment
Session 5: Pre-Competitive Partnerships: Delivering on the Promise
Session 6: Global Health: Incentives and Innovation
5:30 pm – 6:30 pm Speaker/Sponsor Reception
6:30 pm – 7:30 pm Networking Reception
     
15 – Dec 7:00 am – 3:00 pm Registration Open
7:00 am – 8:00 am Breakfast featuring Therapeutic Affinity Roundtables
8:00 am – 9:00 am
Morning Plenary – Bridging the Gap: De-Risking R&D
9:15 am – 1:00 pm Partnering & Expert Consultations
9:15 am – 10:10 am
Session 7: Funding Gap: Can We Afford Innovation?
Session 8: Internationalization of Research: Cures Without Borders
Session 9: Cloud-Sourcing: Collaboration in a Data-Rich Environment
10:15 am – 10:40 am Innovator Presentations 23 - 25
23. Fast Forward – EMD Serono Collaboration
24. Health of Women Study
25. Centre for Drug Research and Development
10:45 am – 11:10 am Innovator Presentations 26 - 28
26. The Accelerator of Cancer Treatments in Children
27. Global Health Portfolio, Foundation for the NIH
28. Hospital Medicine Reengineering Network
11:15 am – 11:40 am Innovator Presentations 29 - 31
29. Neurofibromatosis Preclinical Consortium
30. Parkinson's Progression Markers Initiative
31. Clinical Trial Comparator Arm Partnership
11:45 am – 12:40 pm
Session 10: 21st Century Medicine: Are We There Yet?
Session 11: Deal-Makers and Deal-Breakers: What to Ask Before Investing
Session 12: Cures in the Cupboard: Sharing and Repurposing Assets
1:00 pm – 3:00 pm
Luncheon Plenary – Game-Changing Gifts
3:15 pm – 4:40 pm
 Partnering & Expert Consultations
Please check back regularly for new updates and additions.
© 2010 Partnering for Cures | Terms Of Use  |  Privacy Statement Facebook Twitter Blogger FasterCures